Health - Page 2

Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Protecting the Gut in Animal Studies Health

Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Protecting the Gut in Animal Studies

Researchers at Michigan Medicine report that the experimental drug DT-109 reversed severe fatty liver disease, or MASH, in mice and nonhuman primates by curbing a gut bacterium and strengthening the intestinal barrier that protects the liver.

805
Daily Weight-Loss Pill Orforglipron Outperforms Oral Semaglutide in Major Diabetes Trial Health

Daily Weight-Loss Pill Orforglipron Outperforms Oral Semaglutide in Major Diabetes Trial

In the 52-week ACHIEVE-3 trial, the daily pill orforglipron produced about 74 percent greater weight loss than oral semaglutide in adults with type 2 diabetes, alongside improvements in cholesterol and blood pressure.

899
ApoB Blood Test Outperforms Standard LDL Cholesterol in Predicting Heart Disease Risk Health

ApoB Blood Test Outperforms Standard LDL Cholesterol in Predicting Heart Disease Risk

A major UK Biobank study and updated 2026 ACC/AHA guidelines confirm that apolipoprotein B testing provides superior cardiovascular risk assessment compared to traditional LDL cholesterol measurements.

835
US Heatwave Death Toll Reaches 23 as Extreme Heat Overwhelms Hospitals and Emergency Services Health

US Heatwave Death Toll Reaches 23 as Extreme Heat Overwhelms Hospitals and Emergency Services

At least 23 people have died as record-breaking temperatures overwhelm emergency rooms and knock out power for over 1.3 million households across the eastern United States.

900
Kidney Transplant Crisis: Landmark Study Reveals Half of Referred Patients Never Begin Evaluation Health

Kidney Transplant Crisis: Landmark Study Reveals Half of Referred Patients Never Begin Evaluation

A national study of over 720,000 patients finds that 48 percent of those referred for kidney transplants never begin evaluation, with only 19 percent reaching the waiting list.

742
NHS Approves Groundbreaking Teplizumab Treatment That Delays Type 1 Diabetes Onset by Three Years Health

NHS Approves Groundbreaking Teplizumab Treatment That Delays Type 1 Diabetes Onset by Three Years

England becomes the first country in Europe to approve teplizumab, a disease-modifying therapy that can delay the onset of type 1 diabetes by nearly three years in eligible patients.

1069
Placebo Pills Improve Memory and Physical Performance in Older Adults in Just Three Weeks Health

Placebo Pills Improve Memory and Physical Performance in Older Adults in Just Three Weeks

Italian researchers find that placebo pills, even when participants know they are fake, significantly boost memory, physical performance, and well-being in older adults within three weeks.

820
Galleri Multi-Cancer Blood Test Nears Historic FDA Approval as New Data Shows Seven-Fold Detection Boost Health

Galleri Multi-Cancer Blood Test Nears Historic FDA Approval as New Data Shows Seven-Fold Detection Boost

GRAIL Inc. has completed its FDA application for the Galleri blood test, which can screen for over 50 cancer types and has shown a seven-fold increase in cancer detection rates.

900
Major Scientific Review Concludes Vaping Likely Causes Lung and Oral Cancer Health

Major Scientific Review Concludes Vaping Likely Causes Lung and Oral Cancer

A comprehensive UNSW Sydney review of over 100 studies published in Carcinogenesis concludes that e-cigarette aerosols contain carcinogens triggering biological changes strongly linked to lung and oral cancer development.

887
GLP-1 Drugs Like Ozempic Linked to 30 Percent Lower Breast Cancer Risk Health

GLP-1 Drugs Like Ozempic Linked to 30 Percent Lower Breast Cancer Risk

A large study finds GLP-1 drugs like Ozempic and Wegovy are linked to 30 to 47 percent lower breast cancer risk, even after accounting for weight loss.

821
Common Food Preservatives Linked to Heart Disease Risk in Major Study Health

Common Food Preservatives Linked to Heart Disease Risk in Major Study

A study of over 112,000 people finds that common food preservatives in processed foods are linked to significantly higher risks of high blood pressure and heart disease.

851
GLP-1 Drugs Like Ozempic May Reduce Violent Behavior, Rutgers Study Finds Health

GLP-1 Drugs Like Ozempic May Reduce Violent Behavior, Rutgers Study Finds

A Rutgers University study reveals that GLP-1 receptor agonist drugs like Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior, adding to the growing list of unexpected benefits from these widely prescribed medications.

814

No articles found